Literature DB >> 14678810

Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis.

Yoichi Nakamura1, Kazufumi Nakamura, Kengo Fukushima-Kusano, Keiko Ohta, Hiromi Matsubara, Tsutomu Hamuro, Chikao Yutani, Tohru Ohe.   

Abstract

INTRODUCTION: Tissue factor plays a key role in the extrinsic coagulation pathway and is induced by inflammatory cytokines. Atrial myocarditis has been detected recently in some patients with lone atrial fibrillation. Virchow's triad of low blood flow, hypercoagulability, and endothelial dysfunction, enhances thrombus formation. The present study was designed to elucidate the role of endothelial dysfunction in thrombogenesis associated with nonvalvular atrial fibrillation.
MATERIAL AND METHODS: We investigated tissue factor expression in the endothelia of left atrial appendages obtained from seven patients with nonvalvular atrial fibrillation and cardiogenic thromboembolism. Tissues were divided into 7-13 sections and compared with control specimens from four patients who died of noncardiac events. Expression of tissue factor, von Willebrand factor and tissue factor pathway inhibitor was evaluated by immunohistochemistry.
RESULTS: Histopathologically, inflammatory cells infiltrated the endocardium and all seven patients showed features of persistent myocarditis. Activated T cells [15.3+/-9.4 cells/high power field (HPF, mean+/-S.D.) vs. control 2.2+/-4.4/HPF (P=0.0294)] and a few macrophages [5.1+/-8.4 cells/HPF vs. control 2.4+/-3.5 cells/HPF (P=NS)] infiltrated the endocardium. Tissue factor was overexpressed in the endothelia particularly in tissues containing inflammatory cells and denuded matrix of the endocardium, compared with the control group. Von Willebrand factor, but not tissue factor pathway inhibitor, was also overexpressed in these tissues.
CONCLUSION: Tissue factor expression induced by local inflammation is involved in the pathogenesis of thrombosis in patients with nonvalvular atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14678810     DOI: 10.1016/s0049-3848(03)00405-5

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  41 in total

1.  A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women.

Authors:  David Conen; Paul M Ridker; Brendan M Everett; Usha B Tedrow; Lynda Rose; Nancy R Cook; Julie E Buring; Christine M Albert
Journal:  Eur Heart J       Date:  2010-05-25       Impact factor: 29.983

2.  Left atrial epicardial adiposity and atrial fibrillation.

Authors:  Omar Batal; Paul Schoenhagen; Mingyuan Shao; Ala Eddin Ayyad; David R Van Wagoner; Sandra S Halliburton; Patrick J Tchou; Mina K Chung
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-05-26

Review 3.  Coagulation, protease-activated receptors, and viral myocarditis.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  J Cardiovasc Transl Res       Date:  2013-11-08       Impact factor: 4.132

Review 4.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

5.  Growth differentiation factor 15 is associated with left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.

Authors:  Xiao Feng Hu; Rui Zhan; Shanhu Xu; Junjun Wang; Jiong Wu; Xiaoli Liu; Yaguo Li; Linhui Chen
Journal:  Clin Cardiol       Date:  2018-01-24       Impact factor: 2.882

Review 6.  Inflammation and the pathogenesis of atrial fibrillation.

Authors:  Yu-Feng Hu; Yi-Jen Chen; Yenn-Jiang Lin; Shih-Ann Chen
Journal:  Nat Rev Cardiol       Date:  2015-01-27       Impact factor: 32.419

7.  Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset.

Authors:  Pier Luigi Pellegrino; Natale Daniele Brunetti; Luisa De Gennaro; Luigi Ziccardi; Massimo Grimaldi; Matteo Di Biase
Journal:  Intern Emerg Med       Date:  2011-03-30       Impact factor: 3.397

8.  Atrial fibrillation and percutaneous coronary intervention: stroke, thrombosis, and bleeding.

Authors:  Antonio Gutierrez; Sunil V Rao
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-06

9.  Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage.

Authors:  Boris Leithäuser; Jai-Wun Park
Journal:  Korean Circ J       Date:  2009-11-30       Impact factor: 3.243

10.  Relation of multiple inflammatory biomarkers to incident atrial fibrillation.

Authors:  Renate B Schnabel; Martin G Larson; Jennifer F Yamamoto; Sekar Kathiresan; Jian Rong; Daniel Levy; John F Keaney; Thomas J Wang; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Am J Cardiol       Date:  2009-05-04       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.